608547.G.2.4

  1. Home
  2. Subject Details

Country

United Arab Emirates

HPO Terms

Atrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolism
Back to search Result
Sex

Unknown

Subject Variants

Variant NameAllele CountAllele FrequencyAssociated DiseaseAssociated Gene
NM_024006.6:c.106G>T40.033
Download Table

Remarks

Study including 90 unrelated patients treated with warfarin. Significant difference in average doses of warfarin was observed between patients with different genotypes of rs61742245.

References

Related Subjects

Subject IdCountryHPO TermsSexFamily HistoryParental ConsanguinityRemarks
608547.G.2.1United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'A' of rs9923231 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.2United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'A' of rs9923231 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.3United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Significant difference in average doses of warfarin was observed between patients with different genotypes of rs61742245.
608547.G.2.5United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. No significant difference in average doses of warfarin was observed between patients with different genotypes of rs188009042.
608547.G.2.6United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. No significant difference in average doses of warfarin was observed between patients with different genotypes of rs17708472.
608547.G.2.7United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. No significant difference in average doses of warfarin was observed between patients with different genotypes of rs17708472.
608547.G.2.8United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'T' of rs9934438 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.9United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'T' of rs9934438 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.10United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'C' of rs8050894 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.11United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'C' of rs8050894 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.12United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'T' of rs2359612 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.13United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with minor allele 'T' of rs2359612 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.14United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with major allele 'G' of rs7294 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
608547.G.2.15United Arab EmiratesAtrial fibrillation; Deep vein thrombosis; Cardiomyopathy; Hypercoagulability; Stroke; Pulmonary embolismUnknownStudy including 90 unrelated patients treated with warfarin. Patients with major allele 'G' of rs7294 were observed to be in low or intermediate dose groups that received lower doses of warfarin (less than 6 mg/day).
Back to search Result
© CAGS 2024. All rights reserved.
© CAGS 2024. All rights reserved.